Cover Image

The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti‐Melanoma Differentiation‐Associated Gene 5‐Positive Dermatomyositis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Chen Zong, Shiyu Wu, Longyang Zhu, Yiran Chen, Xinxin Zhang, Chao Sun, Xin Lu, Guochun Wang, Qinglin Peng
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Respirology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferon‐β Triggers Z‐ DNA Binding Protein 1‐Mediated PANoptosis in T Cells of Anti‐Melanoma Differentiation‐Associated Protein 5 Antibody‐Positive Dermatomyositis
by: Xinxin Zhang, et al.
Published: (2026)

Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Target Trial
by: Can Xia, et al.
Published: (2026)

Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Joong‐Yub Kim, et al.
Published: (2025)

Dynapenia and Sarcopenia as Risk Factors for Mortality in Interstitial Lung Disease
by: Alan Aldair Ibarra‐Fernández, et al.
Published: (2025)

Ambient Air Pollution and Risk of ARDS and Mortality in Moderate to Severe COVID ‐19
by: Seohyun Kim, et al.
Published: (2026)

The Underexplored Patterns of Respiratory Risks Associated With Climate Disasters
by: Wenzhong Huang, et al.
Published: (2026)

Diagnostic Dilemma in a Case of Anti‐PL‐7 Antibody‐Positive Interstitial Lung Disease: When Autoimmune Alveolar Proteinosis Masquerades as Anti‐Synthetase Syndrome
by: Beili Liu, et al.
Published: (2025)

Rapid Serological Detection of Anti‐ GM ‐ CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test
by: Chika Narita, et al.
Published: (2025)

What Matters for Prediction? Leukocyte Count and Risk Stratification in Pulmonary Embolism
by: Laura Jayne Bonnett, et al.
Published: (2026)

Anti‐Eukaryotic Initiation Factor 2B ‐Positive Systemic Sclerosis‐Associated Interstitial Lung Disease With Progressive Fibrosis: A Case Report
by: Hiro Ikeda, et al.
Published: (2026)

Prognostic Value of a Cardiopulmonary Exercise Testing‐Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease‐Associated Interstitial Lung Disease: A Prospective Cohort Study
by: Yu‐Lin Tsai, et al.
Published: (2025)

A Rare Case of Anti‐Yo Antibody Positive Paraneoplastic Neurologic Syndromes With EGFR Mutation Positive Non‐Small Cell Lung Cancer
by: Nobuhiro Okagaki, et al.
Published: (2026)

Associations Between Snoring, Body Mass Index and Coronary Artery Diseases: Observational and Mendelian Randomization Study in Asia
by: Yunqing Zhu, et al.
Published: (2025)

Rifampicin‐Associated Sweet Syndrome: An Uncommon Adverse Event of Anti‐Tuberculosis Therapy
by: Sze Kye Teoh, et al.
Published: (2025)

A Case of Anti‐ AMY1 ‐Positive Lung Squamous Cell Carcinoma With Severe Hyperamylasemia Linked to Disease Progression
by: Yusuke Nakamura, et al.
Published: (2026)

Tackling a Lifetime of Risk for OSA
by: Neeraj Mukesh Shah, et al.
Published: (2025)

PMN‐MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis
by: Jielin Duan, et al.
Published: (2025)

Primary Malignant Melanoma of the Lung With a Long‐Term Course: A Case Report
by: Yusei Fukushima, et al.
Published: (2026)

The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature
by: Jieru Lin, et al.
Published: (2025)

Inhaled Corticosteroids for Asthma Treatment in Pregnancy: Benefit Versus Risk?
by: Vanessa E. Murphy
Published: (2025)

Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis
by: John A. Mackintosh, et al.
Published: (2026)

Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk
by: Ibrahim Nagmeldin Hassan
Published: (2025)

Turning Limitations Into Insights: The Path Forward for COPD and Cardiovascular Risk Research
by: Paula Rodriguez‐Miguelez, et al.
Published: (2025)

Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry
by: Mark G. J. P. Platenburg, et al.
Published: (2025)

Association of Endotypic Traits and Their Interaction With Severity of Obstructive Sleep Apnea
by: Liang‐Wen Hang, et al.
Published: (2026)

A Case of Syndrome of Inappropriate Secretion of Antidiuretic Hormone Induced by Selpercatinib in a Patient With RET Fusion Gene‐Positive Non‐Small Cell Lung Cancer
by: Yuma Tanaka, et al.
Published: (2025)

Novel Therapeutics for Chronic Obstructive Pulmonary Disease: From Empirical Bronchodilation to Precision Medicine
by: Naoya Fujino, et al.
Published: (2026)

Broadening Our Understanding of Genetic Risk to Interstitial Lung Disease in Understudied Populations
by: Joanne L. Dickinson
Published: (2025)

Risk Factors for Pneumothorax After Treatment With Endobronchial Valves: A Cohort Study
by: Kirstine Hermann Jørgensen, et al.
Published: (2025)

Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis
by: Xinru Ran, et al.
Published: (2025)

Prediction of post‐operative lung physiology revisited
by: Sylvia Verbanck, et al.
Published: (2024)

High Airway‐To‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD
by: Nobuyasu Wakazono, et al.
Published: (2025)

Respiratory Nurse Leadership Requires Increased Profile, Role Clarity and Stronger Career Pathways: Binational Delphi Consensus Process and TSANZ Position Statement
by: Rebecca Disler, et al.
Published: (2025)

Toward the Development of a Novel Cell Therapy for Pulmonary Arterial Hypertension Using Peripheral Blood Cells
by: Hidekazu Ishida
Published: (2026)

Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”
by: Junyi Bai, et al.
Published: (2025)

Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Prediction Model
by: Daphne J. T. Sjauw, et al.
Published: (2026)

Lymphoid Interstitial Pneumonia Without Known Cause: Diagnostic Work Up and Differential Considerations
by: Han Xin Lau, et al.
Published: (2025)

Early‐to‐Midlife Body Mass Index Trajectories and Obstructive Sleep Apnoea Risk 10 Years Later
by: Yaoyao Qian, et al.
Published: (2025)

Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
by: Chin Kook Rhee, et al.
Published: (2025)

Reply to ‘Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”’
by: Nobuyasu Wakazono, et al.
Published: (2025)